Clinical Development Responsibilities Clause Samples
Clinical Development Responsibilities. Genentech or its Affiliates or sublicensees will be responsible for the clinical development of Genentech Products and will bear all associated costs. In addition, Genentech and/or its Affiliates or sublicensees will be responsible for conducting any necessary pharmacokinetics, toxicology or other IND-enabling studies with respect to such Genentech Products. Subject to Section 2.5, Genentech will use commercially reasonable efforts to develop and to obtain Regulatory Approval of such Genentech Products in the Major Markets and such other markets as Genentech deems is reasonably consistent with generally accepted practices in the pharmaceutical industry. Notwithstanding any other provision of this Agreement, neither Genentech nor its Affiliates or sublicensees shall file an IND covering an indication within the Renovis Field for a Genentech Product that has utility in both the Renovis Field and the Genentech Field unless and until Genentech (or its Affiliates or sublicensees) first files an IND covering an indication in the Genentech Field (but not in the Renovis Field) on that Genentech Product.
Clinical Development Responsibilities. Renovis or its Affiliates or sublicensees will be responsible for the clinical development of such Renovis Products and will bear all associated costs. In addition, if required for IND filing, Renovis and/or its sublicensees will be responsible for conducting pharmacokinetics, toxicology or other IND-enabling studies with respect to such Renovis Products. Renovis will use commercially reasonable efforts to develop and to obtain Regulatory Approval of such Renovis Products in the Major Markets and such other markets as Renovis deems advisable in accordance with generally accepted practices in the pharmaceutical industry.
Clinical Development Responsibilities. Following the end of each applicable Research Term, as between the Parties, ▇▇▇▇▇ shall have the sole right to conduct, and be solely responsible for, as between the Parties, at its sole cost, the Exploitation of all Licensed Compounds and Licensed Products arising from such Research Program, including for preparation and submission of any applicable IND filing and any other Regulatory Filings. As between the Parties, and subject to the terms and conditions of this Agreement, all decisions concerning the foregoing, including the clinical and regulatory strategy of Licensed Products covered under this Agreement, will be within the sole discretion of Lilly.